SpiderRock Advisors’s AbbVie ABBV Stock Holding History

SpiderRock Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$3.14M	Hold	15,900	–	–	0.05%	233
2024 Q2	$2.73M	Hold	15,900	–	–	0.05%	225
2024 Q1	$2.84M	Buy	+15,900	New	+$2.74M	0.07%	205
2023 Q4	–	Hold	0	–	–	–	58
2023 Q3	–	Hold	0	–	–	–	48
2023 Q2	–	Hold	0	–	–	–	43
2023 Q1	–	Hold	0	–	–	–	38
2022 Q4	–	Hold	0	–	–	–	108
2022 Q3	–	Hold	0	–	–	–	109
2022 Q2	–	Hold	0	–	–	–	101
2022 Q1	–	Hold	0	–	–	–	151
2021 Q4	–	Hold	0	–	–	–	148
2021 Q3	–	Hold	0	–	–	–	138
2021 Q2	–	Hold	0	–	–	–	157
2021 Q1	–	Hold	0	–	–	–	168
2020 Q4	–	Hold	0	–	–	–	164
2020 Q3	–	Hold	0	–	–	–	121
2020 Q2	–	Hold	0	–	–	–	55
2020 Q1	–	Hold	0	–	–	–	78
2019 Q4	–	Hold	0	–	–	–	19
2019 Q3	–	Hold	0	–	–	–	28
2019 Q2	–	Hold	0	–	–	–	14
2017 Q3	–	Hold	0	–	-$1K	–	713
2017 Q2	–	Hold	0	–	–	–	780
2017 Q1	–	Hold	0	–	–	–	667

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

SpiderRock Advisors's ABBV Position: Q3 2024 in Review

SpiderRock Advisors increased its AbbVie (ABBV) stake by 19% in Q3 2024, buying an estimated $8.95M and bringing the position to 294,518 shares worth $58.2M. The position accounts for 0.93% of the portfolio, ranked #18.

SpiderRock Advisors first reported a position in ABBV in Q1 2024 and has held it in 3 quarters since. 3,498 funds tracked by Wall St. Rank hold ABBV as of Q3 2024.

SpiderRock Advisors held 294,518 shares of AbbVie worth $58.2M as of Q3 2024.
SpiderRock Advisors bought 47,954 AbbVie shares in Q3 2024, an estimated $8.95M.
AbbVie made up 0.93% of SpiderRock Advisors's portfolio in Q3 2024, its #18 holding.
SpiderRock Advisors first reported a position in AbbVie in Q1 2024 and has held it in 3 quarters since.
3,498 funds tracked by Wall St. Rank held AbbVie as of Q3 2024.

Based on SpiderRock Advisors's 13F filing for Q3 2024, filed 1 Nov 2024.